Drugs / MSC-KI-PL-204
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04290182 | Mar 2021 → Jan 2025 | chronic laryngitis, voice disorders | Karolinska University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC-KI-PL-204 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04290182 ↗ |
| Modality | Cell therapy | “While cell therapy with autologous MSC was classified according to the Tissue Legislation before 2015, it is now regarded as drug treatment.” NCT04290182 ↗ |
| Route | Other | “local injection of autologous bone marrow MSC” NCT04290182 ↗ |